🎢 Your Options Alert for Oct 24 (Friday)

Open Email...Your Power Lunch Trades Ideads Inside…

Unsubscribe ✅ Make this one trade by 2:59 PM on Friday (You will thank me on Monday morning) (ad) Dear Reader, I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of options signals for the next trading day (to help you cut your research in finding trading and/or investing opportunities). The Next Antiviral Leader That Could Disrupt Multi-Billion Markets (ad)* NanoViricides (NYSE: NNVC) is pioneering a new era in antiviral medicine with NV-387, a broad-spectrum antiviral currently in Phase II trials. Unlike traditional drugs, NV-387 can neutralize multiple viruses — from Influenza and RSV to COVID-19 and MPox — without first identifying the culprit. Backed by strong safety data and animal models showing superior efficacy to existing treatments, NV-387 could reshape how viral infections are managed globally. With potential orphan drug designations and a growing antiviral pipeline, NNVC is positioned for explosive growth in a multi-billion-dollar market. 💡 Discover how NV-387 could transform viral treatment — and investor portfolios alike. Stock Name Signal Date Signal Name BRK-A Oct 24 Golden Crossover BRK-B Oct 24 Golden Crossover TMUS Oct 24 Golden Crossover TXN Oct 24 Golden Crossover NFLX Oct 24 Below 200-MA SAP Oct 24 Below 200-MA NOW Oct 24 Below 200-MA BX Oct 24 Below 200-MA PLTR Oct 24 Double Top IBM Oct 24 Double Top UL Oct 24 Double Top CDNS Oct 24 Double Top SBUX Oct 24 Double Bottom MKC Oct 24 Double Bottom DOW Oct 24 Double Bottom BF-A Oct 24 Double Bottom Click Here to View Your Full Report 🚀 Catch It Before the Crowd Does (ad) The best trades often start quietly before the headlines and before the rush. We've just spotted a small-cap showing the right signals: strong earnings potential, sector momentum, and a float that could move fast once volume kicks in. This could be one of those setups you look back on and think, "Glad I saw it early." 📝 Grab your free report now. How to use signals in your trading/investing strategies: Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's trade signal) or the Price Reversal strategy (to target the reversal following signal generation). Please click on Ride-the-Wave Strategy to learn more about it. Stock Trading - If you're a swing stock trader/investor or portfolio manager, you may want to consider entering or exiting your positiosn based on a the signal generation. Please click on Volatility Crush Strategy to learn more about it. 💰 A Tiny Biotech Poised to Disrupt the $100B+ Antiviral Market (ad)* NanoViricides, Inc. (NYSE: NNVC) may be the small biotech about to make the biggest antiviral leap in decades. Its breakthrough drug NV-387 targets a multi-billion-dollar market by treating viral infections without needing to know which virus caused them. Currently in Phase II trials, NV-387 has shown remarkable results against Influenza, COVID-19, RSV, and MPox, with excellent safety in humans. Add orphan drug benefits and Priority Review Voucher potential, and NNVC could soon stand among major pharma names. Investors are taking notice — and this could be just the beginning. 📈 Learn how NNVC could disrupt the global antiviral industry. At Options Hero, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. To your trading success, Support Team Options Hero PS:Options Hero is morning newsletter, powered by StockEarnings proprietary technology. Earnings Season is Here. Ready to trade Earnings Announcements? Don't miss out on earnings plays. My free eBook reveals 3 key strategies for potential profits. Plus, get daily trade ideas. Click Here and Get Your FREE "Earnings Plays" eBook.

(ad)* This message is a PAID ADVERTISEMENT for NanoViricides, Inc (NYSE: NNVC) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $7,000 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between Oct 24, 2025 and Oct 30, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either NanoViricides, Inc (NYSE: NNVC) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding NanoViricides, Inc (NYSE: NNVC) on Smallcaps Daily website for additional information about the relationship between Interactive Offers and NanoViricides, Inc (NYSE: NNVC). Options Hero is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. StockEarnings Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS Unsubscribe Today's Bonus Content: Washington's richest don't follow the market - they move it